Uloric is a medication that contains the active substance febuxostat and is used in the treatment of hyperuricemia (elevated levels of uric acid in the blood) in patients with gout. Febuxostat works by inhibiting an enzyme called xanthine oxidase, which is responsible for the production of uric acid in the body. By reducing uric acid production, Uloric helps prevent the formation of uric acid crystals in the joints, alleviating gout symptoms and preventing acute attacks. Uloric is administered orally, in tablet form, and the recommended dosage is determined by the physician, taking into account the severity of hyperuricemia and the individual patient’s response. It is important to follow medical instructions regarding the correct dosage, proper frequency of administration, and duration of treatment.